SCHEMBL15917918

SCHEMBL15917918

COc1ccc(Oc2cc(C(F)(F)F)c(Cl)cc2C(=O)Nc2ccc(C(=O)O)nc2)c(Cl)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15561708 0.90 — —
SCHEMBL15918582 0.89 — —
SCHEMBL15561910 0.89 SCN8A (0.64) —
SCHEMBL21130228 0.86 — —
SCHEMBL15561804 0.84 — —
SCHEMBL15561879 0.83 — —
SCHEMBL21129720 0.82 — —
SCHEMBL21130144 0.82 — —
SCHEMBL15561795 0.79 SCN8A (0.65) —
SCHEMBL15561943 0.79 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9421196-B2 Amides as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2016-08-23 — — US disclosed
US-20150328196-A1 AMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED 2015-11-19 — — US disclosed
US-9108903-B2 Amides as modulators of sodium channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2015-08-18 — — US disclosed
US-20140221435-A1 AMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS INCORPORATED (US) 2014-08-07 — — US disclosed
Send feedback